Quarterly report · Q1
3353.TEDINET S100U1RT
Period2024-03-01 → 2024-05-31
Filed2024-07-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.2bn | 2024-03-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥39.9bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.7bn | 2023-03-01 → 2023-05-31 | Cons. | Net sales |
| Operating income | ¥429m | 2024-03-01 → 2024-05-31 | Cons. | Operating income |
| Operating income | ¥294m | 2023-03-01 → 2023-05-31 | Cons. | Operating income |
| Ordinary income | ¥431m | 2024-03-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥338m | 2023-03-01 → 2023-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥671m | 2024-03-01 → 2024-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥375m | 2023-03-01 → 2023-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥429m | 2024-03-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.0bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥212m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥436m | 2024-03-01 → 2024-05-31 | Cons. | Profit loss |
| Net income | ¥224m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss |
| Total assets | ¥31.8bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥31.7bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥28.1bn | at 2023-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.6bn | at 2024-05-31 | Cons. | Liabilities |
| Total liabilities | ¥17.8bn | at 2024-02-29 | Cons. | Liabilities |
| Net assets / equity | ¥14.2bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.8bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2023-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.9bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.7bn | at 2024-02-29 | Cons. | Cash and deposits |
| EPS (basic) | ¥114.23 | 2024-03-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥276.7 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.42 | 2023-03-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.7% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.8% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-03-01 → 2024-05-31 | −¥204m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-03-01 → 2024-05-31 | −¥204m |
| Reconciling Itemsreconciling | segment profit | 2024-03-01 → 2024-05-31 | −¥58m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥5.8bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥5.8bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥311m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥50m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥3.6bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥3.4bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥202m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥94m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥46m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥45m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥1m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥32m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-03-01 → 2024-05-31 | ¥11.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-03-01 → 2024-05-31 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥204m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-03-01 → 2024-05-31 | ¥487m |
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-05-31 | −¥141m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥329m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥50m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥1.1bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥810m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥275m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥23m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥47m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥46m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥1m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-03-01 → 2023-05-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-03-01 → 2023-05-31 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥277m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-03-01 → 2023-05-31 | ¥435m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 364
| Item | Context | Value | Unit |
|---|---|---|---|
| Electronically recorded obligations operating cl | Prior1YearInstant | 333540000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 366511000 | JPY |
| Short term loans payable | Prior1YearInstant | 1345000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 1145000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 2349864000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 2258576000 | JPY |
| Income taxes payable | Prior1YearInstant | 380593000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 329173000 | JPY |
| Provision for bonuses | Prior1YearInstant | 276259000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 491870000 | JPY |
| Other cl | Prior1YearInstant | 820856000 | JPY |
| Other cl | CurrentQuarterInstant | 992909000 | JPY |
| Current liabilities | Prior1YearInstant | 10404006000 | JPY |
| Current liabilities | CurrentQuarterInstant | 10526396000 | JPY |
| Long term loans payable | Prior1YearInstant | 5717480000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 5351862000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 166606000 | JPY |
| Lease obligations ncl | CurrentQuarterInstant | 183302000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1016554000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 1041796000 | JPY |
| Other ncl | Prior1YearInstant | 513653000 | JPY |
| Other ncl | CurrentQuarterInstant | 515468000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 7414294000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 7092429000 | JPY |
| Liabilities | Prior1YearInstant | 17818300000 | JPY |
| Liabilities | CurrentQuarterInstant | 17618826000 | JPY |
| Capital stock | Prior1YearInstant | 917000000 | JPY |
| Capital stock | CurrentQuarterInstant | 917000000 | JPY |
| Capital surplus | Prior1YearInstant | 1081749000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1081749000 | JPY |
| Retained earnings | Prior1YearInstant | 11447448000 | JPY |
| Retained earnings | CurrentQuarterInstant | 11782822000 | JPY |
| Treasury stock | Prior1YearInstant | -537933000 | JPY |
| Treasury stock | CurrentQuarterInstant | -537933000 | JPY |
| Shareholders equity | Prior1YearInstant | 12908264000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 13243638000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 332990000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 336090000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -406000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -304000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 332584000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 335785000 | JPY |
| Non controlling interests | Prior1YearInstant | 600341000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 606574000 | JPY |
| Net assets | Prior1YearInstant | 13841190000 | JPY |
| Net assets | CurrentQuarterInstant | 14185998000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 31659490000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 31804824000 | JPY |
| Net sales | Prior1YTDDuration | 8721952000 | JPY |
| Net sales | CurrentYTDDuration | 11183769000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |